Form 4: Precigen Executive Sells Shares
Insider Transaction (Form 4)
Phil Tennant, Chief Commercial Officer of Precigen, Inc., sold 79,166 shares of common stock on August 23, 2026 for $7.50 per share.
Summary
- Option exercise/conversion: acquired 5,208 Common Stock on August 23, 2026; holds 144,577 after (Direct).
- Tax/exercise-price withholding: disposed of 2,585 Common Stock at $7.20 ($18,612) on August 23, 2026; holds 141,992 after (Direct).
- Option exercise/conversion: acquired 79,166 Common Stock at $1.61 ($127,457) on August 25, 2026; holds 221,158 after (Direct).
- Open-market sale: disposed of 79,166 Common Stock at $7.50 ($593,745) on August 25, 2026; holds 141,992 after (Direct).
- Option exercise/conversion: disposed of 5,208 Restricted Stock Units on August 23, 2026; holds 57,292 after (Direct).
- Option exercise/conversion: disposed of 79,166 Option to Purchase Common Stock (Right to Buy) on August 25, 2026; holds 120,834 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $593,745 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Phil Tennant — Officer (Chief Commercial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-23 | Option exercise/conversion | Common Stock | 5,208 | — | — | 144,577 |
| 2026-08-23 | Tax/exercise-price withholding | Common Stock | 2,585 | $7 | $18.6K | 141,992 |
| 2026-08-25 | Option exercise/conversion | Common Stock | 79,166 | $2 | $127.5K | 221,158 |
| 2026-08-25 | Open-market sale | Common Stock | 79,166 | $8 | $593.7K | 141,992 |
| 2026-08-23 | Option exercise/conversion | Restricted Stock Units | 5,208 | — | — | 57,292 |
| 2026-08-25 | Option exercise/conversion | Option to Purchase Common Stock (Right to Buy) | 79,166 | — | — | 120,834 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-23 | Option exercise/conversion (5,208 shares) |
| 2026-08-23 | Tax/exercise-price withholding (2,585 shares) |
| 2026-08-25 | Option exercise/conversion (79,166 shares) |
| 2026-08-25 | Open-market sale (79,166 shares) |
| 2026-08-23 | Option exercise/conversion (5,208 shares) |
| 2026-08-25 | Option exercise/conversion (79,166 shares) |
Keywords
insider transaction, Form 4, PGEN, PRECIGEN, INC., bearish, Phil Tennant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.